Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc TRIB is 20.71%. Trinity Biotech's ROA for the same period is 5.89%. The trailing-twelve-month profit margin at Meridian Bioscience VIVO is 19.23%. Meridian Bioscience's revenue for the same period is $173.54 million. The trailing-twelve-month profit margin at IDEXX Laboratories IDXX is 13.50%. IDEXX Laboratories' PEG ratio is 1.91. The trailing-twelve-month profit margin at Neogen NEOG is 12.35%. Neogen's ROE for the same period is 10.90%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDiagnostic Substances IndustryHighest Profit Margin
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!